Skip to main content
logo
Crescent Biopharma, Inc. (CBIO)
NASDAQ: CBIO · Real-Time Price · USD
17.75
-0.01 (-0.06%)
Aug 28, 2026, 4:00 PM EDT - Market closed

Crescent Biopharma Balance Sheet

Millions USD. Fiscal year is Jan - Dec.

Assets

Fiscal Year
TTMFY 2025FY 2024
Period Ending
Jun '26 Dec '25 Dec '24
Cash & Equivalents
171.59213.1934.77
Cash & Short-Term Investments
171.59213.1934.77
Cash Growth
-513.22%-
Receivables
-18-
Prepaid Expenses
7.415.460.04
Total Current Assets
179.01236.6634.8
Property, Plant & Equipment
2.152.32-
Other Long-Term Assets
1.611.320.81
Total Assets
182.76240.2935.62

Liabilities

Fiscal Year
TTMFY 2025FY 2024
Period Ending
Jun '26 Dec '25 Dec '24
Accounts Payable
2.54100.11
Accrued Expenses
7.418.489.45
Current Portion of Leases
0.470.44-
Current Unearned Revenue
3.124.16-
Other Current Liabilities
5130.06
Total Current Liabilities
18.5436.079.61
Long-Term Debt
--37.48
Long-Term Leases
0.971.21-
Total Liabilities
19.537.2847.1

Shareholders' Equity

Fiscal Year
TTMFY 2025FY 2024
Period Ending
Jun '26 Dec '25 Dec '24
Common Stock
0.030.030
Additional Paid-In Capital
379.16370.792.39
Retained Earnings
-219.93-171.81-17.87
Total Common Equity
159.26199.01-15.48
Shareholders' Equity
163.26203.01-11.48
Total Liabilities & Equity
182.76240.2935.62

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024
Period Ending
Jun '26 Dec '25 Dec '24
Total Debt
1.441.6437.48
Net Cash (Debt)
170.16211.55-2.72
Net Cash Growth
---
Net Cash Per Share
6.2117.61-3.54
Filing Date Shares Outstanding
42.833.217.05
Total Common Shares Outstanding
33.4133.217.05
Working Capital
160.47200.5825.19
Book Value Per Share
4.775.99-2.20
Tangible Book Value
159.26199.01-15.48
Tangible Book Value Per Share
4.775.99-2.20
SEC Filings: 10-K · 10-Q